AI搭載の処方適格性審査ツール

家

AIプロンプト一覧

医療健康

処方審査アシスタント

${:__('collect %s',処方審査アシスタント)}$

医療健康

AI技術を活用し、薬剤師の処方審査を支援し、潜在的な薬物相互作用、投与量エラー、禁忌症を特定し、投薬の安全性と効率を向上させます。

プロンプト内容

コピー

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male with a history of hypertension, type 2 diabetes, and mild renal impairment. The current prescription includes Amoxicillin, Metformin, Amlodipine, and Ibuprofen. Focus on analyzing potential drug-drug interactions, specifically the impact of NSAIDs on renal function and blood pressure, as well as potential interactions between antibiotics and hypoglycemic agents, and provide adjustment suggestions or warnings.

コピー

シニア臨床薬剤師として振る舞い、以下の患者の処方の適合性を審査してください。患者は65歳の男性で、高血圧、2型糖尿病、軽度の腎機能不全の既往歴があります。現在の処方にはアモキシシリン、メトホルミン、アムロジピン、イブプロフェンが含まれています。特に、NSAIDsの腎機能および血圧への影響、ならびに抗生物質と低血糖薬の潜在的な相互作用に焦点を当て、調整提案または警告を提供してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to identify potential risks and output a structured report including risk level, specific rationale, and adjustment recommendations to ensure patient medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists including dosage, frequency, and route. Second, based on the latest clinical guidelines and package inserts, check for drug-drug interactions, contraindications, and dosage adjustments for special populations such as those with hepatic or renal impairment. Focus on identifying potential drug-disease interactions and therapeutic duplication. Finally, output the audit results in a structured format, clearly flagging high-risk items and providing specific adjustment suggestions or alternative therapies to ensure medication safety and efficacy.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness. Identify any risk points according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations to ensure patient medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist. Based on the provided patient demographics, medical history, and the list of medications to be prescribed, perform a prescription appropriateness review. Focus on analyzing drug-drug interactions, dosage appropriateness, and contraindications. Provide clear safety recommendations or adjustment plans based on the latest clinical guidelines to ensure patient medication safety.

処方審査アシスタント

Act as a senior clinical pharmacist and review the following prescription according to the latest clinical medication guidelines: The patient is a 65-year-old male diagnosed with type 2 diabetes and mild renal insufficiency (eGFR 45ml/min). The current prescription includes metformin, glimepiride, and aspirin. Focus on evaluating the necessity of dose adjustment for metformin in the context of renal insufficiency, analyze the hypoglycemia risk associated with glimepiride, and check for potential interactions between aspirin and anticoagulants. Finally, provide specific dosage adjustment recommendations or alternative drug suggestions to ensure the safety and efficacy of the medication regimen.

処方箋審査アシスタント

Act as a senior clinical pharmacist responsible for real-time compliance review of prescriptions within an electronic medical record system. Based on the patient's current diagnosis, medical history, allergies, and concurrent medications, strictly cross-reference the latest clinical guidelines and drug labels to analyze the appropriateness of indications, dosages, routes of administration, and duration for each drug in the prescription. Prioritize identifying potential drug-drug interactions, drug-disease contraindications, or off-label use risks. If potential issues are found, clearly specify the risk type and provide evidence-based alternative solutions or adjustment recommendations; if the prescription is compliant, confirm its safety. Finally, output a structured, professional audit opinion for clinical decision support, without any introductory remarks or explanatory text.